Abstract
Retrospective chart reviews of seven adolescent and young adults with autistic disorder treated with fluoxetine alone or in combination with other medications were performed. Patient's ages varied from 9–20 years (M ± SD, = 16 ± 3.87). Fluoxetine doses ranged from 20–80 mg per day (M ± SD of final doses 37.14 ± 21). Duration of treatment ranged from 1.3–32 months (M 18.04 ± 10.39). Patients' symptoms were monitored using the Aberrant Behavior Checklist (ABC) rating scale during every visit. Side effects included initial appetite suppression, vivid dreams, and hyperactivity. Improvement from baseline was seen in four subscales: irritability (21%), lethargy (37%), stereotypy (27%), and inappropriate speech (21%). Lethargy subscales improved significantly during treatment (p < .029). Hyperactivity subscale increased by 14% but did not attain statistical significance. Fluoxetine appears to have important behavioral effects in treatment of clinic-referred autistic children. Future double-blind placebo controlled studies evaluating core and associated symptom response with fluoxetine are warranted.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.), (pp. 66–71). Washington, DC: Author.
Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89, 485–491.
Bauman, M. L. (1991). Microscopic neuroanatomic abnormalities in autism. Pediatrics, 87(suppl.), 791–796.
Bauman, M. L. (1996). Brief report: neuroanatomic observations of the brain in pervasive developmental disorders. Journal of Autism and Developmental Disorders, 26, 199–203.
Cook, E. H. (1990). Autism: Review of neurochemical investigation. Synapse, 6, 292–308.
Cook, E. H., Rowlett, R., Jaselskis, C., & Leventhal, B. L. (1992). Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 739–745.
Cook, E. H. (1996). Brief report: Pathophysiology of autism: Neurochemistry. Journal of Autism and Developmental Disorder, 26, 221–225.
Cook, E. H., Courchesne, R., Lord, C., Cox, N. J., Yan, S., Lincoln, A., Hass, R., Courchesne, E., & Leventhal, B. L. (1997). Evidence of linkage between the serotonin transporter and autistic disorder. Molecular Psychiatry, 2, 247–250.
Devane, C. L., & Sallee, F. R. (1996). Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: A review of published experience. Journal of Clinical Psychiatry, 57, 55–66.
Ghaziuddin, M., Tsai, L., & Ghaziuddin, N. (1991). Fluoxetine in autism with depression. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 508–509.
Gordon, C. T., State, R. C., Nelson, J. E., Hamburger, S. D., & Rapoport, J. L. (1993). A double-blind comparison of clomipramine, desipramine and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441–447.
Koshes, R. J. (1997). Use of fluoxetine for obsessive-compulsive behavior in adults with autism. American Journal of Psychiatry, 154, 578.
McBride, P. A., Anderson, G. M., Hertzig, M. E., Sweeney, J. A., Kream, J., Cohen, D. J., & Mann, J. (1989). Serotonergic responsivity in male young adults with autistic disorder. Archives of General Psychiatry, 46, 213–221.
McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53, 1001–1008.
McDougle, C. J., Price, L. H., & Goodman, W. K. (1990). Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: A case report. Journal of Autism and Developmental Disorders, 20, 537–543.
Mehlinger, R., Scheftner, W. A., & Poznanski, E. (1990). Fluoxetine and autism. Journal of American Academy of Child and Adolescent Psychiatry, 29, 985.
Todd, R. D. (1991). Fluoxetine in autism. American Journal of Psychiatry, 148, 1089.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fatemi, S.H., Realmuto, G.M., Khan, L. et al. Fluoxetine in Treatment of Adolescent Patients with Autism: A Longitudinal Open Trial. J Autism Dev Disord 28, 303–307 (1998). https://doi.org/10.1023/A:1026008602540
Issue Date:
DOI: https://doi.org/10.1023/A:1026008602540